• Profile
Close

Long-term follow-up and risk factors for strictures after hepaticojejunostomy for bile duct injury: An analysis of surgical and percutaneous treatment in a tertiary center

Surgery Feb 24, 2018

Booij KAC, et al. - The short- and long-term outcomes of hepaticojejunostomy for bile duct injury, including risk factors for strictures, were analyzed. Researchers recognized that hepaticojejunostomy was a relatively safe treatment of bile duct injury. Long-term stricture rate was affected by the timing of surgery and intermediate repair; most anastomotic strictures could be treated successfully with percutaneous dilation.

Methods

  • Researchers performed an analysis of outcome of hepaticojejunostomy in bile duct injury patients referred to a multidisciplinary team.

Results

  • From 1991 to 2016, researchers recognized 281 patients who underwent hepaticojejunostomy for bile duct injury.
  • Thirty-one patients (11%) experienced Clavien-Dindo grade III complications and 90-day mortality occurred in 2 patients (0.7%).
  • They found clinically relevant strictures in 37 patients (13.2%) after a median follow-up of 10.5 years (interquartile range 6.7–14.8 years).
  • Strictures were treated with percutaneous dilatation in 33 patients (89.2%), and re-operation was performed on 4 patients (1.4%).
  • Patients undergoing hepaticojejunostomy <14 days, between 14–90 days, and >90 days after bile duct injury showed stricture rates of 15.8%, 18.7%, and 9.9%, respectively.
  • No differences were found in the stricture rate for early vs intermediate and late repair (P=0.766 and 0.431, respectively).
  • However, the stricture rate for repair after 14–90 days compared with repair >90 days after bile duct injury was higher (P=0.045).
  • As per multivariable analysis, the only independent variable associated with stricture formation was male gender(OR 6.7, 95% CI 1.8–25.4, P=0.005).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay